Clinical Trial Update: Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of pegylated interferon plus ribavirin plus nitazoxanide in patients with Hepatitis C genotype 4 coinfected with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Nitazoxanide (nitazoxanide)
• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Juan Macías | Conditions: HCV Coinfection, HIV Infection | Phase 2 | Status: UNKNOWN